Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9298 USD | -1.09% | -0.45% | -28.48% |
03-26 | Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-19 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Chart calendar Enveric Biosciences, Inc.
Upcoming events on Enveric Biosciences, Inc.
Past events on Enveric Biosciences, Inc.
07/01/2024 | Biotech Showcase |
13/11/2023 21:01 | Q3 2023 Earnings Release |
02/11/2023 14:00 | Annual General Meeting |
31/10/2023 | Canadian Chemical Engineering Conference - Dr. Jillian Hagel |
29/10/2023 | Canadian Chemical Engineering Conference |
25/10/2023 19:10 | Centurion One Global Summit |
09/10/2023 | Neuropsychiatric Drug Development Summit |
17/09/2023 | Molecular Biology and Biochemistry International Conference |
11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
14/08/2023 13:00 | Q2 2023 Earnings Release |
26/06/2023 12:00 | H.C. Wainwright Neuropsychiatry Virtual Conference |
04/06/2023 | BIO International Convention |
27/05/2023 | Canadian Neuroscience Annual Meeting |
15/05/2023 14:25 | Q1 2023 Earnings Release |
03/04/2023 21:05 | Q4 2022 Earnings Release |
02/03/2023 22:00 | Gravitas Securities Growth Conference |
02/03/2023 21:40 | Gravitas Securities Growth Conference - Panel |
06/02/2023 20:00 | BIO CEO and Investor Conference |
10/01/2023 18:00 | Biotech Showcase |
08/01/2023 | JP Morgan Healthcare Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -14,8 -14,8 0.21% | -13,7 |
EBIT Million USD | Released Forecast Spread | 0,00 | -25,9 -17,7 -46.68% | -20,0 -20,7 3.65% | -16,4 -18,6 11.46% | -16,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -56,4 -10,9 -417.01% | 0,00 0,00 - | -17,3 -18,0 4.16% | -18,0 |
Net income Million USD | Released Forecast Spread | -6,86 | -49,0 -10,9 -349.23% | -18,5 -17,9 -3.35% | -17,5 -18,1 3.62% | -18,0 |
EPS USD | Released Forecast Spread | -59,5 | -104 -25,5 -305.88% | -13,0 -12,5 -4.33% | -8,09 -8,17 0.98% | -2,08 |
Announcement Date | 01/04/21 | 31/03/22 | 31/03/23 | 26/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | ||||
EBIT Million USD | Released Forecast Spread | -12,3 -4,04 -204.22% | -4,80 -3,69 -29.93% | -4,71 -4,79 1.65% | -5,66 -5,08 -11.27% | -4,80 -5,80 17.21% | -5,67 -1,50 -277.9% | -3,45 -4,75 27.4% | -2,38 -3,70 35.56% | ||||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -49,6 -4,04 -1125.83% | -4,52 -3,69 -22.57% | -2,87 -4,82 40.42% | -2,48 -4,92 49.6% | -3,41 -3,40 -0.4% | |||||||||
Net income Million USD | Released Forecast Spread | -42,1 -4,03 -944.67% | -4,52 -3,91 -15.59% | -2,87 -4,82 40.42% | -2,60 -4,92 47.08% | -4,68 | -3,44 -3,40 -1.06% | ||||||||
EPS USD | Released Forecast Spread | -86,5 -8,00 -981.25% | -5,50 -6,00 8.33% | -2,73 -4,50 39.33% | -1,46 -4,50 67.56% | -2,31 | -1,30 -1,93 32.64% | -1,47 -1,55 4.85% | -0,61 | -0,55 | -0,52 | -0,40 | -0,40 | ||
Announcement Date | 31/03/22 | 13/05/22 | 12/08/22 | 14/11/22 | 31/03/23 | 15/05/23 | 11/08/23 | 13/11/23 | 26/03/24 | - | - | - | - | - |
Past sector events for Enveric Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ENVB Stock
- Calendar Enveric Biosciences, Inc.